Literature DB >> 23284063

Incidence of stroke in people with Alzheimer disease: a national register-based approach.

Anna-Maija Tolppanen1, Piia Lavikainen, Alina Solomon, Miia Kivipelto, Hilkka Soininen, Sirpa Hartikainen.   

Abstract

OBJECTIVE: Stroke increases the risk of dementias, including Alzheimer disease (AD), but it is unknown whether persons with AD have a higher risk of strokes. We investigated whether noninstitutionalized persons with AD were more likely to experience incident stroke than persons without AD and whether there are differences in the incidence of ischemic or hemorrhagic strokes.
METHODS: We performed a register-based matched cohort study including all community-dwelling persons with verified clinical diagnosis of AD, residing in Finland on December 31, 2005, and a single age-, sex-, and region of residence-matched comparison person without AD for each individual with AD (n = 56,186, mean age 79.6 [SD 6.9] years). Persons with previous strokes and their matched participants were excluded, leaving 50,808 individuals with 2,947 incident strokes occurring between January 1, 2006, and December 31, 2009. Diagnosis of AD was based on prescription reimbursement register and diagnosis of stroke on hospital discharge register of Finland.
RESULTS: AD dementia was not associated with risk of all strokes or ischemic strokes, but the risk of hemorrhagic strokes was higher among persons with AD (adjusted hazard ratio [95% confidence interval] 1.34 [1.12-1.61]). When the associations were analyzed according to age groups, AD was associated with higher risk of all strokes, regardless of etiology, in the 2 youngest age groups, but not in the older groups. Similar associations were observed when the results were categorized according to age at diagnosis.
CONCLUSIONS: Our findings suggest that persons with AD dementia, especially younger patients, have higher risk of hemorrhagic strokes.

Entities:  

Mesh:

Year:  2013        PMID: 23284063     DOI: 10.1212/WNL.0b013e31827f08c5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells.

Authors:  Dominic D Quintana; Jorge A Garcia; Yamini Anantula; Stephanie L Rellick; Elizabeth B Engler-Chiurazzi; Saumyendra N Sarkar; Candice M Brown; James W Simpkins
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 2.  Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.

Authors:  Cátia Janota; Cynthia A Lemere; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2015-07-05       Impact factor: 5.590

3.  Brain arterial aging and its relationship to Alzheimer dementia.

Authors:  Jose Gutierrez; Lawrence Honig; Mitchell S V Elkind; Jay P Mohr; James Goldman; Andrew J Dwork; Susan Morgello; Randolph S Marshall
Journal:  Neurology       Date:  2016-03-16       Impact factor: 9.910

4.  Vascular and Metabolic Factors in Alzheimer's Disease and Related Dementias: Introduction.

Authors:  Costantino Iadecola
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

Review 5.  Alzheimer's silent partner: cerebral amyloid angiopathy.

Authors:  Tanya L Cupino; Matthew K Zabel
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

6.  The association of depression, cognitive impairment without dementia, and dementia with risk of ischemic stroke: a cohort study.

Authors:  Dimitry S Davydow; Deborah A Levine; Kara Zivin; Wayne J Katon; Kenneth M Langa
Journal:  Psychosom Med       Date:  2015 Feb-Mar       Impact factor: 4.312

Review 7.  Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: A synthesis of the literature.

Authors:  Reem Waziry; Lori B Chibnik; Daniel Bos; M Kamran Ikram; Albert Hofman
Journal:  Neurology       Date:  2020-01-16       Impact factor: 9.910

Review 8.  Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both?

Authors:  Ryszard Pluta; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

9.  Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study.

Authors:  Anna-Maija Tolppanen; Heidi Taipale; Marjaana Koponen; Piia Lavikainen; Antti Tanskanen; Jari Tiihonen; Sirpa Hartikainen
Journal:  Clin Epidemiol       Date:  2013-08-07       Impact factor: 4.790

Review 10.  Targeting Common Signaling Pathways for the Treatment of Stroke and Alzheimer's: a Comprehensive Review.

Authors:  Sedigheh Eskandari; Soraya Sajadimajd; Loghman Alaei; Zhaleh Soheilikhah; Hossein Derakhshankhah; Gholamreza Bahrami
Journal:  Neurotox Res       Date:  2021-06-25       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.